Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1579 |
Angiotensin I/II (1-6)
Angiotensin I/II 1-6 |
RAAS; Others | Endocrinology/Hormones; Others |
Angiotensin I/II (1-6) 是由血管紧张素 I/II 肽转化而来,含有 1-6 个氨基酸的多肽。血管紧张素 I 被血管紧张素转换酶水解,形成具有生物活性的血管紧张素 II。血管紧张素 II 用于高血压、特发性膜性肾病和肾素-血管紧张素系统的研究。 | |||
T36622 |
Angiotensin I/II (1-6) (TFA)
|
||
Angiotensin I/II (1-6) TFA is a chemical compound comprising amino acids 1-6. It is derived from the Angiotensin I/II peptide, which is formed by the cleavage of the precursor angiotensinogen by renin. The resulting Angiotensin I is then hydrolyzed by angiotensin-converting enzyme (ACE) to produce biologically active Angiotensin II. Angiotensin II has been extensively studied for its potential applications in the treatment of Hypertension, Renin Angiotensin System, and Idiopathic Membranous Neph... | |||
T7663L |
Angiotensin 1/2 (1-9) TFA(34273-12-6(free base))
|
Others | Others |
Angiotensin 1/2 (1-9) TFA(34273-12-6(free base)) 含有从血管紧张素 I/II 肽转化而来的氨基酸 1-9。 | |||
T75733 |
Saralasin TFA
|
||
Saralasin ([Sar1,Ala8] Angiotensin II) TFA,血管紧张素 II (angiotensin II) 的八肽衍生物,作为竞争性血管紧张素 II 受体 (angiotensin II receptor) 拮抗剂,其Ki值达0.32 nM(涵盖74%的结合位点),显示出部分激动剂特性。适应于肾血管性高血压、肾素依赖性(血管紧张素原性)高血压的研究。 |